Skip to main content
. 2018 Jun 13;8:9067. doi: 10.1038/s41598-018-27391-4

Figure 2.

Figure 2

Perinatal iron exposures and risk of type 1 diabetes. (a) Risk of type 1 diabetes in the offspring by use of iron-containing supplements during pregnancy. Picture: ©Can Stock Photo/Eraxion, ©Can Stock Photo/adekvat and from http://www.ebi.ac.uk/. (b) Maternal iron supplement use, type of supplement used, duration of iron supplements and risk of type 1 diabetes. (c) Cord blood ferritin and soluble transferrin receptor (TfR) among children who later developed type 1 diabetes (cases) and randomly selected controls from the same cohort. (d) Maternal and fetal HFE genotype among children who later developed type 1 diabetes (cases) and randomly selected controls from the same cohort. Panel b and c Adjusted for maternal age and education, smoking, parity, pre-pregnancy BMI, mode of delivery, birth weight and prematurity, maternal type 1 diabetes, maternal celiac disease and diagnosed maternal anaemia (<17 weeks). Panel c additionally adjusted for year of birth. Ferritin quartiles: 1st quartile < 96 mg/L, 2nd quartile 96–142 mg/L, 3rd quartile 142.1–207 mg/L, 4th quartile >207 mg/L. sTFR quartiles: 1st quartile <2.15 mg/L, 2nd quartile 2.15–2.63 mg/L, 3rd quartile 2.631–3.31 mg/L, 4th quartile >3.31 mg/L. Panel d Reciprocally adjustment for maternal/fetal genotype Standard genotype: Wild type HFE allele at both loci (C282 and H63). Intermediate genotype: p.63D/63D homozygotes and 63D or 282Y heterozygotes High genotype: p.282Y homozygous or p.282Y/63D compound heterozygotes.